<DOC>
	<DOCNO>NCT01176370</DOCNO>
	<brief_summary>The C-Pulse Study evaluate safety performance new product treatment heart failure . The product design help reduce symptom heart failure help patient function good daily activity . The study evaluate multiple measure heart function whether patient 's quality life improve since device implant . The patient several visit device implant ass well monitor safety concern .</brief_summary>
	<brief_title>The Purpose Study Evaluate Whether Use C-Pulse™ Treatment Patients Moderate Severe Heart Failure ( HF ) Associated With Reasonable Assurance Safety Performance</brief_title>
	<detailed_description>Sunshine Heart Inc. sponsor prospective trial ass safety provide indication performance Sunshine Heart C-PulseTM System ( `` C-Pulse™ '' ) . The current need counterpulsation device method effective enough make application appeal long-term implant large number patient physician . It must simple safe , straight-forward implant procedure , long-term measurable patient benefit . Further , would advantageous counterpulsation device small , easy insert , ambulatory , disconnectable , bloodstream . Such device may readily adopt wide group cardiologist surgeon , suitable wider group people NYHA Class III IV heart failure . It important point counterpulsation device aim augment native heart function fundamentally different total artificial heart , leave ventricular assist device heart transplant meant total replacement alternative native heart . Thus , counterpulsation device consider non-obligatory life-supporting . Sunshine Heart , Inc propose C-Pulse™ , novel ambulatory , non-obligatory , non-blood contact extra-ascending aortic counterpulsation system . The C-Pulse™ System design implant without need cardiopulmonary bypass extensive dissection , able activate immediately , augment heart function safe manner provide sustain relief heart failure symptom . It turn safely , similarly , failure mode , consider associate low risk death disability , recurrence heart failure symptom . C-Pulse™ alternative heart , augmentation device , preclude use therapy provide full circulatory support heart transplantation LVADs . The C-Pulse™ System consist counterpulsation Cuff secure around outside ascend aorta , main blood vessel heart . The Cuff heart signal sense wire attach external driver . The external Driver inflate deflates Cuff sequence ECG signal assist heart function improve pump capacity heart . The Cuff deflect aorta `` thumb-printing '' manner optimize minimize aortic wall strain maximize blood volume displacement per beat . The C-Pulse™ System non-blood contacting , simple insert , turn require ; natural blood pathway maintain - exposure foreign material bloodstream .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient ACC/AHA Stage C heart failure remain NYHA Class III ambulatory Class IV despite optimal medical therapy . ACE inhibitor ARB ( Angiotensin Receptor Blocks ) least 30 day precede implant nitrate/hydralazine investigator discretion Betablocker least 90 day stable 30 day precede implant Patient leave ventricular ejection fraction ( LVEF ) ≤ 35 % Patient Cardiac Resynchronization Therapy ( CRT ) least 90 day prior enrollment indicate CRT device Patient implant cardiodefibrillator ( ICD ) least 30 day prior enrollment indicate ICD implantation . Patient least 18 year age old 75 year Patient six minute hall walk assessment 100350 meter Patient understand nature procedure , willing comply associate followup evaluation , provide write informed consent prior procedure Patient evidence : Ascending aortic calcification posterioranterior lateral chest xray initial screening OR Atherosclerotic ascend aortic disease , specifically intimal thicken great 3mm mobile atheroma ( moderate ) mural calcification ( severe ) detect CT scan echocardiography ( Echo ) Patient ascend aortocoronary artery bypass graft , history aortic dissection , Marfans disease connective tissue disorder aortic root replacement Patient aorta conform specify dimensional constraint define CT scan , specifically mid ascend aortic outside diameter le 29mm great 40mm Patient severe mitral valve incompetence , grade 4+ Patient moderate severe aortic valve incompetence , grade 24+ Patient systolic blood pressure le 90 great 140 mmHg Patient Serum Sodium le 130 mEq/L Patient Estimated Glomerular Filtration Rate ( GFR ) less 40 ml/min/1.73m2 Patient two three Bilirubin , Aspartate Aminotransferase ( AST ) , Alanine Aminotransferase ( ALT ) great three time upper limit normal Patient serum Albumin le 3.0 g/dL Patient Body Mass Index ( BMI ) less 18 great 40 kg/m2 Patient active infection Patient myocardial infarction ( MI ) , stroke , transient ischemic attack ( TIA ) , cardiac major surgery , 90 day prior enrollment Patient severe Chronic Obstructive Pulmonary Disease ( COPD ) evidence Forces Expiratory Volume ( FEV1 ) less equal 0.9 L/min Patient require concomitant surgical procedure [ i.e . coronary artery bypass graft ( CABG ) , Valve repair ] Patient support leave ventricular assist device IABP Severe Right Heart Dysfunction systemic venous congestion evidence clinical signs/symptoms Central Venous Pressure ( CVP ) ≥ 20 mmHg , Cardiac Index ( CI ) &lt; 2.0 l/min./m2 , elevate liver function test beyond three time upper limit normal presence ascites Patient reversible cause heart failure may remedied conventional surgery intervention Patient pregnant ; Note : Negative pregnancy test require woman child bear potential Patient condition , opinion investigator , would disqualify patient inclusion study , limit survival less one year , permit valid consideration Patient currently enrol participate last 30 day another therapeutic interventional clinical study likely confound study result Patient symptomatic Carotid artery disease asymptomatic disease stenosis great 70 % .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Device</keyword>
	<keyword>Implantable</keyword>
	<keyword>Active</keyword>
	<keyword>Class III Class IV</keyword>
	<keyword>Counterpulsation</keyword>
</DOC>